Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
ImprimisRx NJ

ImprimisRx NJ Recalls

All product recalls associated with ImprimisRx NJ.

Get alerts for this brand

Recall Summary

Total Recalls

Past Year

Class I (Serious)

Most Recent

Nov 2022

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–3 of 3 recalls

Timolol-Latanoprost Drops (ImprimisRx) – Subpotent Drug (2022)

Subpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost.

Class IIModerate

FDANov 9, 2022Nationwide• ImprimisRx NJ

Timolol-Dorzolamide-Latanoprost Drops (ImprimisRx) – Subpotent Drug (2019)

Subpotent Drug

Class IIModerate

FDAJul 17, 2019Nationwide• ImprimisRx NJ

Timolol-Latanoprost Drops (ImprimisRx) – Subpotent Drug (2019)

Subpotent Drug

Class IIModerate

FDAJul 17, 2019Nationwide• ImprimisRx NJ